Navigation Links
The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
Date:2/26/2009

profit 2,863 7,643 11,413 18,556 Sales & marketing expenses 2,508 1,084 5,958 4,995 Administrative expenses 1,743 3,177 7,943 9,627 Research & development 612 1,690 4,242 6,482 Income taxes (benefit) - - - - Income (Loss) from: operations Continuing operations (1,965) 1,818 (6,410) (1,856) Discontinued operations - (157) 876 (602) Net Income (Loss) (1,965) 1,661 (5,534) (2,458) Diluted income (loss) per share: Continuing operations ($0.15) $0.13 ($0.50) ($0.14) Discontinued operations - ($0.01) $0.07 ($0.05) Net income (loss) ($0.15) $0.12 ($0.43) ($0.19) Diluted weighted average common shares outstanding: 12,905,883 13,396,497 12,877,983 12,728,706
    Consolidated Balance Sheets (Unaudited)

    The following represents condensed financial data (in thousands)
     at December 31, 2008 and 2007:

                                           2008      2007
                                            ($)       ($)

    Cash & cash equivalents              11,957    15,134
    Accounts receivable, net              4,524     6,649

    Inventory                             3,001     4,136
    Total current assets                 20,666    28,835
    Total assets                         24,369    33,502
    Total current liabilities             6,595    10,258
    Total stockholders' equity           17,774    23,244



'/>"/>
SOURCE Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
2. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
3. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
4. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
5. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
6. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
7. Service Corporation International Announces Fourth Quarter 2008 Financial Results and Comments on Outlook for 2009
8. Heyltex Corporation to Become Exclusive Distributor of ThyroShield(R)
9. CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application
10. Providence Service Corporation Announces Bylaw Amendments to Improve Corporate Governance
11. Service Corporation International Announces Schedule for Its Fourth Quarter 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... to light at night, which shuts off nighttime production ... to tamoxifen, a widely used breast cancer drug, says ... cancer researchers. The study, "Circadian and Melatonin Disruption by ... Tamoxifen Therapy in Breast Cancer," published in the journal ... that melatonin is vital to the success of tamoxifen ...
(Date:7/24/2014)... 2014 The report, “Content Delivery ... market into various sub-segments with an in-depth analysis ... drivers and restraints for this market with insights ... market data tables and 36 figures spread through ... Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, ... may be dead wrong, according to a small study that asked ... with 33 boys between the ages of 14 and 16, researchers ... for the closeness and trust. Very few boasted about sexual conquests ... with a girl. "In our culture, we have lots of ...
(Date:7/24/2014)... 24, 2014 Pools and beaches are the ... can be dangerous, especially for small children, so Amica ... , According to the Centers for Disease Control and Prevention, ... at risk for water-related injuries and deaths. It’s important to ... water, so Amica is offering the following tips from the ...
(Date:7/24/2014)... Drinking caffeine may worsen the hot flashes and night ... go through menopause, new survey data suggests. "While ... caffeine intake may be useful for those postmenopausal women ... researcher Dr. Stephanie Faubion, director of the Women,s Health ... But caffeine -- a stimulant found in coffee and ...
Breaking Medicine News(10 mins):Health News:Total darkness at night is key to success of breast cancer therapy -- Tulane study 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2
... 24 UCI Medical Affiliates, Inc. (Other OTC: UCIA) announced ... Finance, Chief Financial Officer, and Secretary of UCI Medical Affiliates, ... federal court to criminal charges for falsifying eight of the ... On the eight reports that were submitted to the ...
... and phosphate content is common, but labeling is not ... -- Additives used to "enhance" uncooked meat and poultry ... disease, researchers say. , Many fresh meat and poultry ... and flavorings that are not required to be listed ...
... , , , ... ), a global leader in the field of radiosurgery, announced today ... Ill., has installed the CyberKnife((R)) Robotic Radiosurgery System in one of ... of this new CyberKnife configuration option, which can save hospitals both ...
... 24 Healthcare Informatics Associates (HIA), an InfoLogix company (Nasdaq: ... Hilo Medical Center (HMC) in Hilo, Hawaii for a multi-year engagement ... Region facilities. , , (Logo: ... , Hilo initially selected HIA among multiple competing vendors ...
... Sick people are being used as a "wedge" in a turf ... experts. , , Some hospitals ... hallways on unit floors, believing that will force nurses to find ... CEO and Vice President, respectively, at TeleTracking Technologies, leading maker of ...
... , , , ... hosted by the Kaiser Permanente Health Care Institute and the National ... for all Americans. Speakers discussed proven strategies for incentivizing coordinated care ... the way we cover health care, without actually reforming care delivery ...
Cached Medicine News:Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to Former Executive Officer Pleading Guilty to Criminal Charges 2Health News:Fresh-Meat Additives May Be Dangerous for Kidney Patients 2Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 2Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 3Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 4Health News:Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation 2Health News:Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation 3Health News:Are Patients Becoming Victims in Hospital Overcrowding Turf Wars? Experts Ask 2Health News:Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs 2Health News:Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs 3
(Date:7/24/2014)... Many new dentists who are opening their own ... their practice will be a success. DentalDisposables.net is here to ... the most can make all the difference. Dentistry is a ... that purchasing discount dental supplies can make the ... successful dentists across the United States ...
(Date:7/24/2014)... , July 24, 2014  Kinex Pharmaceuticals announced the ... the Company,s KX2-391 Ointment for the commencement of a ... the Company,s third IND to be allowed by the ... KX2-391 is a synthetic, orally active and highly selective ... KX2-391 promotes the induction of p53, G2/M arrest of ...
(Date:7/24/2014)... 2014 Research and Markets  has announced ... by Product, Component, Application and Geography - Global Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 ... witness a moderate growth as the markets of the ... reached the saturation levels. The demand is expected to ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... More than a patch, Duragen is ... dura mater. Duragen handles and conforms ... an innovative collagen matrix for dural ... repair of dural defects. Fully resorbed ...
Elmed electrosurgical systems for major surgery....
Aaron 1250 is a multipurpose electrosurgical generator with monopolar and bi-polar functions....
Medicine Products: